YOLFTbeta
47

Johnson Chemical Pharmaceutical Works Co Ltd

4747 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

15.75TWD+1.40 (+9.76%)

Price History

Full chart

Market Stats

Previous Close14.35
Open14.45
Day Range14.45 – 15.75
52-Week Range22.55 – 34.79
Volume1.63M
Market Cap2.09B
P/E (TTM)23.42
Forward P/E0.00
EPS0.98
Dividend Yield2.29%
Beta-0.01
50-Day Avg25.54
200-Day Avg27.04

About

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Baixiong Huang
  • Employees188
  • HeadquartersNo. 77 and No.79, Sanhe Road, New Taipei City, Taiwan, 241, Taiwan
  • Websitehttps://www.jcpjohnson.com.tw

Leadership

  • Mr. Baixiong HuangChairman & CEO
  • Ms. Yixiu ChenFinance Director
  • Mr. Weike LinSales Director
  • Guo An LiaoDeputy General Manager and Director
  • Mr. Peter LinChief Research Officer

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue177.59M201.24M245.30M266.31M313.52M362.05M380.18M392.42M394.61M411.91M425.34M424.01M411.49M494.67M606.71M611.41M569.77M
Growth (%)-+13.32%+21.89%+8.56%+17.73%+15.48%+5.01%+3.22%+0.56%+4.39%+3.26%-0.31%-2.95%+20.21%+22.65%+0.78%-6.81%
Cost of Revenue90.51M94.57M111.04M119.02M133.98M160.04M195.99M212.99M225.43M235.07M233.89M231.83M239.57M290.29M362.08M363.45M341.43M
Gross Profit------184.18M179.43M169.17M176.84M191.45M192.18M171.92M204.38M244.63M247.97M228.35M
Gross Margin------48.45%45.72%42.87%42.93%45.01%45.32%41.78%41.32%40.32%40.56%40.08%
Operating Expense------112.95M106.88M102.76M108.03M112.56M116.65M109.64M121.70M145.72M149.97M155.24M
Operating Income17.59M28.56M46.35M48.98M78.82M82.97M71.24M72.54M66.41M68.81M78.89M75.53M62.28M82.68M98.92M98.00M73.11M
Operating Margin9.90%14.19%18.90%18.39%25.14%22.92%18.74%18.49%16.83%16.70%18.55%17.81%15.14%16.71%16.30%16.03%12.83%
EBITDA--------76.89M79.28M93.63M90.58M78.30M100.86M126.59M133.19M87.46M
EBITDA Margin--------19.49%19.25%22.01%21.36%19.03%20.39%20.87%21.78%15.35%
Net Income16.34M22.68M39.36M48.75M65.79M71.56M62.13M63.45M60.01M57.28M64.47M63.56M49.10M64.85M79.70M84.12M53.51M
Net Income Margin9.20%11.27%16.05%18.30%20.98%19.76%16.34%16.17%15.21%13.91%15.16%14.99%11.93%13.11%13.14%13.76%9.39%
R&D----5.63M14.94M15.72M9.73M6.95M9.32M9.84M13.08M8.92M13.25M17.27M20.76M15.96M
R&D as % of Total Revenue----1.79%4.13%4.13%2.48%1.76%2.26%2.31%3.09%2.17%2.68%2.85%3.40%2.80%
Interest Expense000000000022.00K792.00K1.08M1.06M4.59M3.51M3.75M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.19%0.26%0.21%0.76%0.57%0.66%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets368.69M396.51M441.70M454.24M683.60M752.00M917.57M955.50M931.07M936.82M951.76M1.10B1.03B1.04B1.99B1.97B2.09B
Total Liabilities57.22M72.06M88.30M67.93M100.06M117.00M95.97M123.09M95.64M100.29M103.79M240.33M178.91M167.56M320.99M261.36M384.37M
Total Equity311.47M324.45M353.39M386.30M583.53M635.01M821.60M832.41M835.43M836.53M847.97M858.20M848.24M871.66M1.67B1.70B1.71B
Cash78.42M86.11M108.62M109.38M297.38M331.06M413.16M332.95M305.91M309.81M309.54M295.67M202.23M168.47M1.09B1.07B1.05B

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow28.76M27.81M50.57M28.88M78.70M82.91M41.97M68.25M39.89M68.15M71.52M71.77M52.35M89.69M136.95M62.88M71.71M
Investing Cash Flow-------88.53M-95.90M-9.89M-10.22M-22.26M-161.61M-38.15M-59.92M---
Financing Cash Flow----139.95M-128.66M-52.55M-57.03M-54.03M-49.53M75.97M-107.64M-63.53M---
Capital Expenditure10.15M5.31M14.78M12.26M29.15M12.64M5.27M95.36M3.67M7.33M15.08M162.18M37.29M59.71M33.12M13.19M64.05M
Free Cash Flow--------36.23M60.82M56.44M-90.41M15.06M29.98M103.83M49.68M7.66M
Dividends Paid7.81M9.71M10.41M15.20M20.70M22.95M64.54M52.53M57.03M54.03M49.53M54.03M57.64M43.53M60.04M67.32M78.63M
FCF to OCF--------90.81%89.24%78.91%-125.96%28.77%33.43%75.82%79.02%10.68%
Dividend Paid to FCF--------157.43%88.84%87.76%-59.77%382.76%145.19%57.82%135.50%1026.51%

Earnings

Report DateDec 31, 2013May 14, 2014
EPS Estimate0.290.28
EPS Actual0.530.35
Surprise80.33%25.00%
Timing-Pre-market

Key Statistics & Ratios

Market Cap2.09B
Enterprise Value2.55B
Trailing P/E23.42
Forward P/E0.00
Price / Sales3.61
Price / Book1.24
EPS0.98
Book Value19.12
Revenue (TTM)577.93M
Gross Profit (TTM)227.10M
EBITDA79.33M
Profit Margin15.47%
Operating Margin10.94%
Return on Equity5.25%
Return on Assets1.62%
Shares Outstanding90.92M
Shares Float45.14M
Beta-0.01
Dividend Yield2.29%
Dividend Rate0.53
Payout Ratio53.34%

Dividends

20261×
0.53Jul 6, 2026
20251×
0.88Jun 26, 2025
20241×
0.75Jun 21, 2024
20231×
1.00Jun 12, 2023
20221×
0.66Jun 22, 2022
20211×
0.87Jun 1, 2021
20201×
0.82Jun 11, 2020
20191×
0.75Jun 18, 2019
20181×
0.82Jun 13, 2018
20171×
0.86Jun 13, 2017
20161×
0.79Jun 27, 2016
20151×
0.97Jun 11, 2015
20141×
0.39Jul 30, 2014
20131×
0.40Jul 18, 2013
20121×
0.26Jul 30, 2012

Stock Splits

  • Aug 20, 20262000:1000
  • Jul 30, 20141125:1000
  • Jul 18, 20131.125:1
  • Jul 30, 20121.125:1